Exploratory analysis of survival benefit and prior docetaxel (D) treatment in COU-AA-301, a phase III study of abiraterone acetate (AA) plus prednisone (P) in metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Chi, K. N.; Scher, H. I.; Molina, A.; Logothetis, C.; Jones, R. J.; Staffurth, J.; North, S. A.; Vogelzang, N. J.; Saad, F.; Mainwaring, P. N.; Harland, S. J.; Li, J.; Kheoh, T. S.; Haqq, C. M.; Fizazi, K. |
| Abstract Title: | Exploratory analysis of survival benefit and prior docetaxel (D) treatment in COU-AA-301, a phase III study of abiraterone acetate (AA) plus prednisone (P) in metastatic castration-resistant prostate cancer (mCRPC) |
| Meeting Title: | 2012 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2012 Feb 2-4 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-02-10 |
| Language: | English |
| ACCESSION: | WOS:000208892400017 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.5_suppl.15 |
| Notes: | Meeting Abstract: 15 -- Source: Wos |
